Reelin Depletion is an Early Phenomenon of Alzheimer's Pathology
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Alterations in the expression of Reelin (RELN) have been implicated in the pathology of Alzheimer's disease (AD). However, whether these changes are cause or consequence of AD remains to be resolved. To better understand the role of RELN pathway in the development of AD, we examined the expression profile of RELN and its downstream signaling members APOER2, VLDLR, and DAB1 in AD-vulnerable regions of transgenic and wildtype mice as well as in AD patients and controls across disease stages and/or aging. We show that both AD pathology and aging are associated with perturbation of the RELN pathway in a species-, region-, and molecule-specific manner. Further, we show that depletion of RELN, but not its downstream signaling molecules, is detectable long before the onset of amyloid-β pathology in the murine hippocampus and in a pre-clinical AD stage in the human frontal cortex. This early event hints at a possible causative role of RELN decline in the precipitation of AD pathology and supports RELN's potential as a pre-clinical marker for AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Reelin pathway was recognized to be involved in AD development since its impairment favors amyloidogenic Aβ processing and tau hyperphosphorylation [91,92].”
From The Emerging Role of PCSK9 in the Pathogenesis of Alzheimer’s Disease: A Possible Target for the Disease Treatment (2024) · cites this paper as [92]
In the citing paper
“Altered cleavage of Reelin was also found in AD mice as well as postmortem brain tissue and the cerebrospinal fluid of human AD subjects (89).”
From Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses (2017) · cites this paper as [89]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“AD severity was classified by two neuropathologists utilizing the CERAD [41] and Braak & Braak [42] staging.”
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404 · cited 1×
“Neuropathologically, AD is characterized by neurofibrillary tangles composed of hyperphosphorylated tau [18] and senile plaques [19], representing”
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · cited 1×
“AD severity was classified by two neuropathologists utilizing the CERAD [41] and Braak & Braak [42] staging.”
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
A protein related to extracellular matrix proteins deleted in the mouse mutant reeler
D'Arcangelo, G., G. Miao, G., Chen, S.-C., Scares, H. D., Morgan, J. I., & Curran, T. (1995) · Nature · doi:10.1038/374719a0 · Cited by 1,748 · cited 1×
“During developmental stages, RELN is strongly expressed by Cajal-Retzius neurons [8], enabling proper neocortical lamination and cerebellar foliation [9–12].”
Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A., & Herz, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80782-5 · Cited by 1,261
Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955 · cited 1×
“[40] were analyzed at different stages of the disease”
Hiesberger, T., Trommsdorff, M., Howell, B. W., Goffinet, A., Mumby, M. C., Cooper, J. A., & Herz, J. (1999) · Neuron · doi:10.1016/s0896-6273(00)80861-2 · Cited by 916 · cited 2×
“Reelin (RELN) is a highly conserved extracellular glycoprotein with signaling properties, predominantly mediated by the binding of processed RELN fragments to the membranous apolipoprotein E receptor 2 (APOER2, also known as LRP8) and the very low density lipoprotein receptor (VLDLR), which in turn induces the phospho…”
Haass, C., Koo, E. H., Mellon, A., Hung, A. Y., & Selkoe, D. J. (1992) · Nature · doi:10.1038/357500a0 · Cited by 899 · cited 1×
“precursor (A PP) [20].”
Reelin Is a Ligand for Lipoprotein Receptors
D'Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D. S., Sheldon, M., & Curran, T. (1999) · Neuron · doi:10.1016/s0896-6273(00)80860-0 · Cited by 808 · cited 1×
“[4, 5] essential for neuronal migration and positioning [6, 7].”
apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771 · cited 2×
“APOER2 as well as VLDLR gene polymorphisms have been demonstrated for AD patients [35, 36] and for VLDLR, an A clearance function across the blood-brain-barrier has been reported [37].”
Lavdas, A. A., Grigoriou, M., Pachnis, V., & Parnavelas, J. G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-07881.1999 · Cited by 765 · cited 1×
“In the adult nervous system, RELN expression is mainly restricted to neocortical, hippocampal (HC), entorhinal (EC), and cerebellar neurons [13, 14].”
Tissir, F., & Goffinet, A. M. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1113 · Cited by 751 · cited 1×
“During developmental stages, RELN is strongly expressed by Cajal-Retzius neurons [8], enabling proper neocortical lamination and cerebellar foliation [9–12].”
Caviness, V. S. (1982) · Developmental Brain Research · doi:10.1016/0165-3806(82)90141-9 · Cited by 639 · cited 1×
“During developmental stages, RELN is strongly expressed by Cajal-Retzius neurons [8], enabling proper neocortical lamination and cerebellar foliation [9–12].”
Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning
Weeber, E. J., Beffert, U., Jones, C., Christian, J. M., Förster, E., Sweatt, J. D., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205147200 · Cited by 623 · cited 1×
“During adulthood, the RELN pathway modulates synaptic transmission [15, 16], neurite growth, and dendritic spine development [17], thereby facilitating memory and learning performance.”
Reelin, lipoprotein receptors and synaptic plasticity
Herz, J., & Chen, Y. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn2009 · Cited by 524 · cited 1×
“The fact that transgenic mice harboring a mutated A (cid:1) PP develop RELN deficiency supports consequence of artificially induced AD-like pathology. the other hand, previous work revealed that crossing of heterozygous reeler mice with transgenic AD [32].”
Beffert, U., Weeber, E. J., Durudas, A., Qiu, S., Masiulis, I., Sweatt, J. D., Li, W.-P., Adelmann, G., Frotscher, M., Hammer, R. E., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.07.007 · Cited by 497
Caviness, V. S., & Sidman, R. L. (1973) · Journal of Comparative Neurology · doi:10.1002/cne.901480202 · Cited by 413 · cited 1×
“During developmental stages, RELN is strongly expressed by Cajal-Retzius neurons [8], enabling proper neocortical lamination and cerebellar foliation [9–12].”
Anatomical, Physiological and biochemical studies of the cerebellum from reeler mutant mouse
Mariani, J., Crepel, F., Mikoshiba, K., Changeux, J. P., & Sotelo, C. (1977) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1977.0121 · Cited by 397 · cited 1×
“During developmental stages, RELN is strongly expressed by Cajal-Retzius neurons [8], enabling proper neocortical lamination and cerebellar foliation [9–12].”
The entorhinal cortex of the mouse: Organization of the projection to the hippocampal formation
van Groen, T., Miettinen, P., & Kadish, I. (2003) · Hippocampus · doi:10.1002/hipo.10037 · Cited by 346 · cited 1×
“rites probably project from entorhinal neurons and integrate into hippocampal CA4 and CA3 via the perforant pathway [46].”
Reelin-mediated Signaling Locally Regulates Protein Kinase B/Akt and Glycogen Synthase Kinase 3β
Beffert, U., Morfini, G., Bock, H. H., Reyna, H., Brady, S. T., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209205200 · Cited by 306 · cited 1×
“inhibits regulators of tau phosphorylation [1, 21–23]”
Reelin modulates NMDA receptor activity in cortical neurons
Chen, Y., Beffert, U., Ertunc, M., Tang, T.-S., Kavalali, E. T., Bezprozvanny, I., & Herz, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1951-05.2005 · Cited by 299 · cited 1×
“During adulthood, the RELN pathway modulates synaptic transmission [15, 16], neurite growth, and dendritic spine development [17], thereby facilitating memory and learning performance.”
Reelin expression and glycosylation patterns are altered in Alzheimer’s disease
Botella-López, A., Burgaya, F., Gavín, R., García-Ayllón, M. S., Gómez-Tortosa, E., Peña-Casanova, J., Ureña, J. M., Del Río, J. A., Blesa, R., Soriano, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601279103 · Cited by 221 · cited 2×
“In contrast to our results showing RELN depletion in the frontal cortex of AD patients, Botella-Lopez and colleagues reported on increased RELN mRNA and protein levels in AD-affected frontal cortices [28, 30].”
Interaction of Reelin with Amyloid Precursor Protein Promotes Neurite Outgrowth
Hoe, H.-S., Lee, K. J., Carney, R. S. E., Lee, J., Markova, A., Lee, J.-Y., Howell, B. W., Hyman, B. T., Pak, D. T. S., Bu, G., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4872-08.2009 · Cited by 219 · cited 1×
“[26].”
Ramos, B., Baglietto-Vargas, D., Rio, J. C. D., Moreno-Gonzalez, I., Santa-Maria, C., Jimenez, S., Caballero, C., Lopez-Tellez, J. F., Khan, Z. U., Ruano, D., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.022 · Cited by 216 · cited 1×
“[44] and AD [45], it is possible that the observed loss”
Bock, H. H., Jossin, Y., Liu, P., Förster, E., May, P., Goffinet, A. M., & Herz, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306416200 · Cited by 213 · cited 1×
“[4, 5] essential for neuronal migration and positioning [6, 7].”
Jossin, Y., Ignatova, N., Hiesberger, T., Herz, J., Lambert de Rouvroit, C., & Goffinet, A. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3408-03.2004 · Cited by 198 · cited 1×
“Reelin (RELN) is a highly conserved extracellular glycoprotein with signaling properties, predominantly mediated by the binding of processed RELN fragments to the membranous apolipoprotein E receptor 2 (APOER2, also known as LRP8) and the very low density lipoprotein receptor (VLDLR), which in turn induces the phospho…”
Receptor Clustering Is Involved in Reelin Signaling
Strasser, V., Fasching, D., Hauser, C., Mayer, H., Bock, H. H., Hiesberger, T., Herz, J., Weeber, E. J., Sweatt, J. D., Pramatarova, A., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1378-1386.2004 · Cited by 193 · cited 1×
“Reelin (RELN) is a highly conserved extracellular glycoprotein with signaling properties, predominantly mediated by the binding of processed RELN fragments to the membranous apolipoprotein E receptor 2 (APOER2, also known as LRP8) and the very low density lipoprotein receptor (VLDLR), which in turn induces the phospho…”
Chin, J., Massaro, C. M., Palop, J. J., Thwin, M. T., Yu, G.-Q., Bien-Ly, N., Bender, A., & Mucke, L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3758-06.2007 · Cited by 188 · cited 2×
“RELN depletion in the entorhinal cortex of transgenic mice and humans with AD in a full-blown stage of pathology has been previously shown [31].”
DAB1 and Reelin effects on amyloid precursor protein and ApoE receptor 2 trafficking and processing
Hoe, H.-S., Tran, T. S., Matsuoka, Y., Howell, B. W., & Rebeck, G. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602162200 · Cited by 174
Reelin signaling antagonizes β-amyloid at the synapse
Durakoglugil, M. S., Chen, Y., White, C. L., Kavalali, E. T., & Herz, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908176106 · Cited by 153 · cited 1×
“synaptic dysfunction [27].”
Kocherhans, S., Madhusudan, A., Doehner, J., Breu, K. S., Nitsch, R. M., Fritschy, J.-M., & Knuesel, I. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0418-10.2010 · Cited by 132 · cited 2×
“On the other hand, previous work revealed that crossing of heterozygous reeler mice with transgenic AD mice results in offspring with accelerated AD-like pathology [32].”
Ramos‐Moreno, T., Galazo, M. J., Porrero, C., Martínez‐Cerdeño, V., & Clascá, F. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04567.x · Cited by 128 · cited 3×
“There exists evidence that RELN produced by entorhinal neurons is transported across perforant pathway neurites and released at terminals in the dentate gyrus and stratum lacunosum, inducing a diffuse extracellular RELN staining [14, 47].”
Hoe, H.-S., Wessner, D., Beffert, U., Becker, A. G., Matsuoka, Y., & Rebeck, G. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9259-9268.2005 · Cited by 122 · cited 2×
“APOER2 can bind to A (cid:1) PP, resulting in retained A (cid:1) PP endocytosis, thereby favoring non-amyloidogenic A (cid:1) PP processing [33].”
Beffert, U., Weeber, E. J., Morfini, G., Ko, J., Brady, S. T., Tsai, L.-H., Sweatt, J. D., & Herz, J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4084-03.2004 · Cited by 117 · cited 1×
“inhibits regulators of tau phosphorylation [1, 21–23]”
Ohkubo, N., Lee, Y., Morishima, A., Terashima, T., Kikkawa, S., Tohyama, M., Sakanaka, M., Tanaka, J., Maeda, N., Vitek, M. P., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0434fje · Cited by 117 · cited 1×
“inhibits regulators of tau phosphorylation [1, 21–23]”
Rat hippocampal GABAergic molecular markers are differentially affected by ageing
Vela, J., Gutierrez, A., Vitorica, J., & Ruano, D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01681.x · Cited by 100 · cited 1×
“[44] and AD [45], it is possible that the observed loss”
Age-related accumulation of Reelin in amyloid-like deposits
Knuesel, I., Nyffeler, M., Mormède, C., Muhia, M., Meyer, U., Pietropaolo, S., Yee, B. K., Pryce, C. R., LaFerla, F. M., Marighetto, A., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.011 · Cited by 94 · cited 2×
“[49] who showed RELN aggregates in the brains of aged (P360 and older) wildtype mice, disease-free mice included in our study remained free of RELN deposits until the latest investigated age (P210).”
Genetic Modulation of Tau Phosphorylation in the Mouse
Brich, J., Shie, F.-S., Howell, B. W., Li, R., Tus, K., Wakeland, E. K., Jin, L.-W., Mumby, M., Churchill, G., Herz, J., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00187.2003 · Cited by 85 · cited 1×
“The fact that transgenic mice harboring a mutated A (cid:1) PP develop RELN deficiency supports consequence of artificially induced AD-like pathology. the other hand, previous work revealed that crossing of heterozygous reeler mice with transgenic AD [32].”
Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease
Sáez‐Valero, J., Costell, M., Sjögren, M., Andreasen, N., Blennow, K., & Luque, J. M. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10554 · Cited by 78 · cited 1×
“cerebrospinal fluid of AD patients, RELN levels have been reported to be increased [28–30], whereas in adult transgenic mice in a full-blown stage of AD-like pathology, the number of RELN expressing pyramidal neurons was reduced in the EC, accompanied by decreased HC RELN levels [31].”
Reelin in plaques of β-amyloid precursor protein and presenilin-1 double-transgenic mice
Wirths, O., Multhaup, G., Czech, C., Blanchard, V., Tremp, G. L., Pradier, L., Beyreuther, K. T., & Bayer, T. A. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02399-0 · Cited by 66
β-amyloid controls altered Reelin expression and processing in Alzheimer's disease
Botella-López, A., Cuchillo-Ibáñez, I., Cotrufo, T., Mok, S. S., Li, Q.-X., Barquero, M.-S., Dierssen, M., Soriano, E., & Sáez-Valero, J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.006 · Cited by 64 · cited 2×
“In contrast to our results showing RELN depletion in the frontal cortex of AD patients, Botella-Lopez and colleagues reported on increased RELN mRNA and protein levels in AD-affected frontal cortices [28, 30].”
Martinez-Cerdeno, V. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.12.1298 · Cited by 63 · cited 1×
“There exists evidence that RELN produced by entorhinal neurons is transported across perforant pathway neurites and released at terminals in the dentate gyrus and stratum lacunosum, inducing a diffuse extracellular RELN staining [14, 47].”
Large Proteins Have a Great Tendency to Aggregate but a Low Propensity to Form Amyloid Fibrils
Ramshini, H., Parrini, C., Relini, A., Zampagni, M., Mannini, B., Pesce, A., Saboury, A. A., Nemat-Gorgani, M., & Chiti, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016075 · Cited by 61 · cited 1×
“They indicate that large proteins accumulate into toxic aggregates without developing amyloid fibrils under conditions effective for amyloid formation [51].”
Doehner, J., Madhusudan, A., Konietzko, U., Fritschy, J.-M., & Knuesel, I. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1333 · Cited by 43 · cited 1×
“In line with previous observations [48–50], we noticed RELN-containing aggregates in murine samples and additionally observed increasing amounts of RELN deposits in human brains along disease progression (from CERAD A/Braak & Braak I-II to CERAD C/Braak & Braak V-VI stage).”
Genetic Risk Factors in Japanese Alzheimer’s Disease Patients: α1-ACT, VLDLR, and ApoE
Yamanaka, H., Kamimura, K., Tanahashi, H., Takahashi, K., Asada, T., & Tabira, T. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00035-9 · Cited by 40 · cited 1×
“APOER2 as well as VLDLR gene polymorphisms have been demonstrated for AD patients [35, 36] and for VLDLR, an A clearance function across the blood-brain-barrier has been reported [37].”
Müller, T., Looße, C., Schrötter, A., Schnabel, A., Helling, S., Egensperger, R., & Marcus, K. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391827 · Cited by 26 · cited 2×
“In either (no matter if cause or consequence), the pre-existing datatogetherwiththepresentedworkillustratethatdis-turbanceoftheRELNpathwayandADcanpromote eachotherinaviciouscircle.”
Regulated Proteolysis of APP and ApoE Receptors
Hoe, H., & Rebeck, G. W. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8017-0 · Cited by 24
Apolipoprotein E receptor 2 is involved in neuritic plaque formation in APP sw mice
Motoi, Y., Itaya, M., Mori, H., Mizuno, Y., Iwasaki, T., Hattori, H., Haga, S., & Ikeda, K. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.081 · Cited by 21 · cited 1×
“In a transgenic mouse model of AD surrounding amyloid plaques and in dystrophic neurites [34].”
Tinsley, C. J., Bennett, G. W., Mayhew, T. M., & Parker, T. L. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7578 · Cited by 17 · cited 1×
“RESULTS”
Low-density lipoprotein receptor-related protein 8 gene polymorphisms and dementia
Helbecque, N., Cottel, D., & Amouyel, P. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.024 · Cited by 11 · cited 1×
“APOER2 as well as VLDLR gene polymorphisms have been demonstrated for AD patients [35, 36] and for VLDLR, an A clearance function across the blood-brain-barrier has been reported [37].”
Cited by
Costa, L. G., Cole, T. B., Dao, K., Chang, Y.-C., Coburn, J., & Garrick, J. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107523 · Cited by 484
“, 2010; Mota, Ferreira, & Rego, 2014b; Yu, Tan, Yu, Xie, & Tan, 2016), and in brains of AD patients, particularly in the early stages (Chin et al., 2007; Herring et al., 2012).”
The involvement of Reelin in neurodevelopmental disorders
Folsom, T. D., & Fatemi, S. H. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.015 · Cited by 275
“…et al. 2003 No change in Reelin expression Increased expression of Reelin 180 kDa in frontal cortex but not cerebellum; altered glycosylation of Reelin Botella López et al. 2006 Reduced expression of Reelin in FC Herring et al. 2012 IR, immunoreactivity; PFC, prefrontal cortex Neuropharmacology.”
BackgroundResultDysfunctional synapse in Alzheimer's disease – A focus on NMDA receptors
Mota, S. I., Ferreira, I. L., & Rego, A. C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.013 · Cited by 206
“Additionally to a decrease in mRNA levels, the decrease in GluN2B and GluN2A subunits could be due also to a decrease in reelin levels, a protein that mediates NMDAR activity, and which is depleted in AD brains (Herring et al., 2012).”
Jossin, Y. (2020) · Biomolecules · doi:10.3390/biom10060964 · Cited by 202
Ramanan, V. K., & Saykin, A. J. (2013) · Europe PMC (PubMed Central) · Cited by 251
Metadata
- Authors
- Herring, A., Donath, A., Steiner, K. M., Widera, M. P., Hamzehian, S., Kanakis, D., Kölble, K., ElAli, A., Hermann, D. M., Paulus, W., & Keyvani, K.
- Affiliations
- Essen University Hospital (DE)
- University Hospital Münster (DE)
- Corresponding author
- Keyvani, Kathy
- ORCID
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2012-06-18
- Volume
- 30
- Issue
- 4
- Pages
- 963-979
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1537020271
- Cited by
- 92
- References
- 51
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 4 · 2016: 13 · 2015: 5 · 2014: 9 · 2013: 9 · 2012: 3
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- reelin, Alzheimer's disease
- MeSH terms
- Reelin Protein, Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Female, Frontal Lobe, Humans, Male, Mice, Inbred C3H, Mice, Inbred C57BL, Mice, Transgenic, Nerve Tissue Proteins, Serine Endopeptidases, Biomarkers, Cell Adhesion Molecules, Neuronal, Extracellular Matrix Proteins, Early Diagnosis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.